Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer

被引:0
作者
Daniel Habermehl
Kerstin Kessel
Thomas Welzel
Holger Hof
Amir Abdollahi
Frank Bergmann
Stefan Rieken
Jürgen Weitz
Jens Werner
Peter Schirmacher
Markus W Büchler
Jürgen Debus
Stephanie E Combs
机构
[1] Im Neuenheimer Feld 400,Department of Radiation Oncology
[2] Im Neuenheimer Feld 110,Department of Visceral Surgery
[3] Im Neuenheimer Feld 220/221,Institute of Pathology
[4] University Hospital of Heidelberg,Department of Radiation Oncology
[5] Im Neuenheimer Feld 400,undefined
来源
Radiation Oncology | / 7卷
关键词
Overall Survival; Pancreatic Cancer; Gemcitabine; Median Overall Survival; Pancreatic Cancer Patient;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 113 条
[1]  
Bramhall SR(1995)Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study Br J Surg 82 111-115
[2]  
Allum WH(1999)Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1-7
[3]  
Jones AG(2008)Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial Strahlenther Onkol 184 450-456
[4]  
Sener SF(2011)Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer: prognostic significance of tumor regression Strahlenther Onkol 187 225-230
[5]  
Fremgen A(2011)Adenocarcinoma of the esophagogastric junction: neoadjuvant radiochemotherapy and radical surgery: early results and toxicity Strahlenther Onkol 187 231-237
[6]  
Menck HR(2004)Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors J Am Coll Surg 198 722-731
[7]  
Dunst J(1996)Long-term survival after curative resection for pancreatic ductal adenocarcinoma. clinicopathologic analysis of 5-year survivors Ann Surg 223 273-279
[8]  
Debus J(2000)Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 567-579
[9]  
Rudat V(1996)Survival after resection for ductal adenocarcinoma of the pancreas Br J Surg 83 625-631
[10]  
Eich HT(1998)Periampullary adenocarcinoma: analysis of 5-year survivors Ann Surg 227 821-831